Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,726 public trials 1,768 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

NCT05417594

Conditions
Adnexal Diseases, Advanced Solid Malignancies, Astrocytoma, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Chicago, Illinois, United States
View all 32 locations
View Trial Details
Recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

NCT05941520

Conditions
Adenocarcinoma, Breast Atypical Hyperplasia, Breast Carcinoma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

NCT06169371

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Illinois Chicago, Illinois, United States
  • Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Astera Cancer Care East Brunswick East Brunswick, New Jersey, United States
  • Instituto de Oncologia de Rosario Rosario, Santa Fe Province, Argentina
  • Centro Oncologico Korben Ciudad Autonoma Buenos Aires, Argentina
View all 30 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details

Related conditions